Enhanced GVHD Prophylaxis an Allogenein Stem Cell Trans*

Weisdorf, Daniel J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 1U01HL069290-01
• Application #: 6439141
• Study Section: Special Emphasis Panel (ZHL1-CSR-F (S1))
• Program Officer: Peterson, Charles M
• Project Start: 2001-09-30
• Project End: 2006-08-31
• Budget Start: 2001-09-30
• Budget End: 2002-08-31
• Support Year: 1
• Fiscal Year: 2001
• Total Cost: $405,000

Institution

• Name: University of Minnesota Twin Cities
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 168559177
• City: Minneapolis
• State: MN
• Country: United States
• Zip Code: 55455

Publications

Weisdorf, Daniel J (2010) How closely related is graft-vs-leukemia to donor/recipient disparity? Best Pract Res Clin Haematol 23:525-8

Pavletic, Steven Z; Kumar, Shaji; Mohty, Mohamad et al. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transpla Biol Blood Marrow Transplant 16:871-90

Weisdorf, Daniel J; Nelson, Gene; Lee, Stephanie J et al. (2009) Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. Biol Blood Marrow Transplant 15:1475-8

Reddy, Pavan; Arora, Mukta; Guimond, Martin et al. (2009) GVHD: a continuing barrier to the safety of allogeneic transplantation. Biol Blood Marrow Transplant 15:162-8